FGFR3 and urothelial carcinoma: Moreover, FGFR3 gene mutations have been detected in 18% of urothelial carcinomas, 14% of uterine carcinosarcomas, 5% of esophageal cancers, 5% of ovarian cancers and 4% of endometrial cancers.